BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22975765)

  • 1. [Immunologically escaped hematopoiesis caused by HLA allelic loss in patients with aplastic anemia].
    Katagiri T; Nakao S
    Rinsho Ketsueki; 2012 Jul; 53(7):651-7. PubMed ID: 22975765
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.
    Imi T; Katagiri T; Hosomichi K; Zaimoku Y; Hoang Nguyen V; Nakagawa N; Tajima A; Yoshizato T; Ogawa S; Nakao S
    Blood Adv; 2018 May; 2(9):1000-1012. PubMed ID: 29720492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.
    Katagiri T; Sato-Otsubo A; Kashiwase K; Morishima S; Sato Y; Mori Y; Kato M; Sanada M; Morishima Y; Hosokawa K; Sasaki Y; Ohtake S; Ogawa S; Nakao S;
    Blood; 2011 Dec; 118(25):6601-9. PubMed ID: 21963603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False homozygous HLA genotyping results due to copy number neutral loss of heterozygosity in acquired aplastic anaemia.
    Heyrman B; De Becker A; Verheyden S; Demanet C
    BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28254831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aplastic anemia: pathogenesis and treatment.
    Bacigalupo A; Piaggio G; Van Lint MT; Figari O; Marmont A; Congiu M
    Onkologie; 1987 Jun; 10(3):172-3. PubMed ID: 3306537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathophysiology of acquired aplastic anemia.
    Young NS; Maciejewski J
    N Engl J Med; 1997 May; 336(19):1365-72. PubMed ID: 9134878
    [No Abstract]   [Full Text] [Related]  

  • 7. [Distribution characteristics of leukocytic antigens in hematopoietic hypoplasia].
    Timoshenko LI; Burka NI
    Vrach Delo; 1978 Jul; (7):55-9. PubMed ID: 685256
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of clonal hematopoiesis in patients with acquired aplastic anemia].
    Nakao S
    Rinsho Ketsueki; 2013 Apr; 54(4):336-42. PubMed ID: 23666214
    [No Abstract]   [Full Text] [Related]  

  • 9. Escape hematopoiesis by HLA-B5401-lacking hematopoietic stem progenitor cells in men with acquired aplastic anemia.
    Elbadry MI; Mizumaki H; Hosokawa K; Espinoza JL; Nakagawa N; Chonabayashi K; Yoshida Y; Katagiri T; Hosomichi K; Zaimoku Y; Imi T; Nguyen MAT; Fujii Y; Tajima A; Ogawa S; Takenaka K; Akashi K; Nakao S
    Haematologica; 2019 Oct; 104(10):e447-e450. PubMed ID: 30890597
    [No Abstract]   [Full Text] [Related]  

  • 10. "Myelophrenia": its contribution to the management of aplastic anemia.
    Nathan DG
    Prog Clin Biol Res; 1984; 148():xxi-xxx. PubMed ID: 6379655
    [No Abstract]   [Full Text] [Related]  

  • 11. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble factors in aplastic anemia with hemolymphopoietic activity.
    Nissen C; Moser Y; Speck B; Bendy J
    Prog Clin Biol Res; 1984; 148():107-18. PubMed ID: 6379656
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of hematopoiesis by a plasma factor in a case of aplastic anemia associated with systemic lupus erythematosus.
    Marqués JA; Rhim H; Distenfeld A
    P R Health Sci J; 1995 Dec; 14(4):293-6. PubMed ID: 8637971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On estimating HLA/disease association with application to a study of aplastic anemia.
    Self SG; Longton G; Kopecky KJ; Liang KY
    Biometrics; 1991 Mar; 47(1):53-61. PubMed ID: 2049513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The human histocompatibility system (HLA) in aplastic anemia (AA) (author's transl)].
    Hurtado Monroy R; Lavalle Montalvo C; Schmill López N; Vega López MA; González Llaven J
    Sangre (Barc); 1980; 25(4):466-70. PubMed ID: 7423338
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement-dependent hematopoietic inhibitors in the sera of patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Takahashi M
    Int J Cell Cloning; 1987 May; 5(3):242-54. PubMed ID: 3598246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating activated suppressor T lymphocytes in aplastic anemia.
    Zoumbos NC; Gascón P; Djeu JY; Trost SR; Young NS
    N Engl J Med; 1985 Jan; 312(5):257-65. PubMed ID: 2981406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory activity of T cells on hematopoiesis and gamma-IFN production by T cells from peripheral blood in patients with aplastic anemia].
    Hanada T; Yamamura H; Ehara T; Nakahara S; Shibuya A; Abe T; Takita H
    Nihon Ketsueki Gakkai Zasshi; 1988 May; 51(3):571-5. PubMed ID: 3138870
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful hematopoietic stem cell transplantation from an HLA-identical sibling in a patient with aplastic anemia after HLA-haploidentical living-related liver transplantation for fulminant hepatitis.
    Yoshimi A; Nannya Y; Ueda K; Asano D; Yamamoto G; Kumano K; Hangaishi A; Matsui Y; Takahashi T; Imai Y; Sugawara Y; Kokudo N; Kurokawa M
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):389-90. PubMed ID: 19203732
    [No Abstract]   [Full Text] [Related]  

  • 20. [Colony formation of bone marrow hematopoietic progenitor cells in patients with severe aplastic anemia and its relation to the results of immunosuppressive therapy].
    Xia C; Chu Y; Shao Z; Zhang J; Tang X; Tian Z; Chen G; Zhang Y; Zhang J
    Zhonghua Xue Ye Xue Za Zhi; 1997 Oct; 18(10):538-40. PubMed ID: 15625831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.